Overactive bladder - PDFSEARCH.IO - Document Search Engine

Overactive bladder
Results: 199

#	Item
81	June 1, 2006 Astellas Launches “Vesicare®” for the treatment of Overactive Bladder in Japan Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Toichi Takenaka) today announced that Vesicar Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-19 00:56:17 Incontinence Overactive bladder Muscarinic antagonists Solifenacin Astellas Pharma Urinary incontinence Urge incontinence Urinary bladder Frequent urination Medicine Urology Anatomy
82	June 18, 2010 Application for Mirabegron (YM178), a Treatment for OAB, in Japan Tokyo, Japan, June 18, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced th Add to Reading List Source URL: www.astellas.com Language: English - Date: 2010-06-17 22:05:31 Overactive bladder Muscarinic antagonists Astellas Pharma Solifenacin Urinary incontinence Frequent urination Urge incontinence Urination Percutaneous tibial nerve stimulation Medicine Urology Incontinence
83	August 29, 2011 Astellas Pharma Inc.: Announcement of Regulatory Submission for Mirabegron (YM178), a Treatment for Overactive Bladder, in U.S. and Europe Tokyo, August 29, [removed]Astellas Pharma Inc. (Tokyo:4503, “As Add to Reading List Source URL: www.astellas.com Language: English - Date: 2011-08-26 02:56:51 Chemistry Incontinence Overactive bladder Solifenacin Urinary incontinence Astellas Pharma Urge incontinence Urinary retention Frequent urination Medicine Urology Muscarinic antagonists
84	September 15, 2011 Astellas Pharma Inc. Launches Betanis® Tablet, a Treatment for OAB, in Japan -Provides a New Option for Patients with OAB Tokyo, Japan, September 15, [removed]Astellas Pharma Inc. (Tokyo:4503,“Astell Add to Reading List Source URL: www.astellas.com Language: English - Date: 2011-09-14 05:44:33 Muscarinic antagonists Overactive bladder Solifenacin Incontinence Astellas Pharma Urinary incontinence Frequent urination Urination Urinary bladder Medicine Anatomy Biology
85	MYRBETRIQ™ (mirabegron), Overactive Bladder Treatment from Astellas, Now Available Through U.S. Pharmacies NORTHBROOK, Ill., Oct. 22, 2012 – Astellas Pharma US, Inc. (“Astellas”), a U.S. subsidiary of Tokyobased Add to Reading List Source URL: www.astellas.com Language: English - Date: 2012-10-22 19:12:22 Overactive bladder Urodynamic testing Urinary incontinence Urinary retention Astellas Pharma Urinary bladder National Association For Continence Frequent urination Percutaneous tibial nerve stimulation Medicine Urology Incontinence
86	Urogenital dysfunction in MSA Jalesh N. Panicker Consultant Neurologist Department of Uro-Neurology National Hospital for Neurology and Neurosurgery and Add to Reading List Source URL: www.msaawareness.org Language: English - Date: 2014-06-23 21:31:12 Urinary system Bladder sphincter dyssynergia Urge incontinence Urination Urology Overactive bladder Urinary bladder Stress incontinence Urethral sphincter Medicine Anatomy Incontinence
87	PRESS RELEASE For immediate release MIRABEGRON RECEIVES POSITIVE CHMP OPINION FOR TREATMENT OF OVERACTIVE BLADDER SYMPTOMS Chertsey, UK, 19th October[removed]ASTELLAS PHARMA EUROPE Ltd. announced today that the Committee f Add to Reading List Source URL: www.astellas.com Language: English - Date: 2012-10-21 18:34:10 Astellas Pharma Tolterodine Benign prostatic hyperplasia Urination Urinary retention Prostate cancer Percutaneous tibial nerve stimulation Medicine Muscarinic antagonists Overactive bladder
88	INNOVATING FOR CONTINENCE: THE ENGINEERING CHALLENGE, 2015 Program Pre-conference Workshops, Wednesday, April 15, 2015 5:30 p.m. - 7:00 p.m. Add to Reading List Source URL: www.innovatingforcontinence.org Language: English - Date: 2014-12-01 22:30:41 Urology Urinary incontinence Fecal incontinence Urinary retention Depend Incontinence pad Bladder Overactive bladder Pelvic floor Medicine Incontinence Health
89	Annex 2 to Final Report Development of an information policy for medicinal products – January 2002 WORKSHOP[removed]September[removed]OVERACTIVE BLADDER / URGE INCONTINENCE Add to Reading List Source URL: www.aesgp.eu Language: English Amines Urinary incontinence Overactive bladder Urge incontinence Oxybutynin Urodynamic testing Tolterodine Urination Overflow incontinence Medicine Incontinence Muscarinic antagonists
90	Advisory Committee Briefing Document Add to Reading List Source URL: www.fda.gov Language: English Tolterodine Chemistry Overactive bladder Organochlorides Organic chemistry Amines Percutaneous tibial nerve stimulation Muscarinic antagonists Phenols Pfizer

UPDATE